2006, Number S2
PDF size: 110.20 Kb.
ABSTRACTSystemic Inflammatory Response (SIR) constitutes generalized, non- specific response to tissue injury of whatever etiology, and is a rapid, highly amplified, controlled humeral and cellular response. Cardiopulmonary Bypass (CPB) is necessary in many cardiac surgery as in adults as children. Also we know the undesirable effects of SIR. The pediatric surgical team to treat of management very well if exist the threat of undesirable outcome after CPB. There are several key components of the inflammatory response to cardiac surgery involve the complement, immune and endothelial systems. Cytokines may exert either proinflammatory or antiinflammatory effects. Cytokines are essential for immunologic and physiologic homeostasis, are normally subject to thight homeostatic control, and are produced in response to a variety of physiologic and pathologic stimuli. An uncontrolled inflammatory response appears to play a significant role in the morbidity or mortality observed in patients undergoing CPB. The inflammatory response contributes to the pathogenesis of acute pulmonary, cardiovascular, neurologic, splanchnic, hematologic, and immune system dysfunction following cardiac surgery. The development of strategies to control the inflammatory response following cardiac surgery is currently the focus of considerable research efforts. Diverse techniques, including maintenance of hemodynamic stability, minimization of exposure to CPB circuitry, and pharmacologic and immunomodulatory agents have been studied. Also hemofiltration, leukodepletion, the use of serine protease inhibitors and corticosteroids. Molecular biology is revolutionizing medicine and the ability to assess the impact of genetic variability on disease characterization and perioperative outcome. Recent evidence suggests that the degree and severity of surgical- induced inflammation may be significantly influenced by genotype.
CHENOWETH DE, COOPER SW, HUGLI TE, STEWART RW, BLACKSTONE EH, KIRKLIN JW: Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497-503.
KIRKLIN JK, WESTABY S, BLACKSTONE EH, KIRKLIN JW, CHENOWETH DE, PACIFICO AD: Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-857.
MOAT NE, SHORE DF, EVANS TW: Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 1993; 7: 563-73.
MC BRIDE WT, ARMSTRONG MA, GILLILAND H, MC MURRAY TJ: The balance of pro and anti- inflammatory cytokines in plasma and bronchoalveolar lavage (BAL) at pediatric cardiac surgery. Cytokine 1996; 8: 724-729.
HAUSER GJ, BEN-ARI J, COLVIN MP, DALTON HJ, BEARB M, HOPKINS RA, WALKER SM: Interleukin-6 levels in serum and lung lavage fluid of children undergoing open heart surgery correlate with postoperative morbidity. Intens Care Med 1998; 24: 481-486.
MC BRIDE WT, ARMSTRONG MA, CROCKARD AD, MC MURRAY TJ, REA JM: Cytokine balance and immunosuppresive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. B J Anaesth 1995; 75: 724-733.
JOURNOIS D, ISRAEL-BIET D, POUARD P, ROLLAND B, SILVESTER W, VOUNE P, SAFRAN D: High volume, zero balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 1996; 85: 965-76.
HÖVELS-GÜRICH HH, SCHUMACKER K, VAZQUEZ-JIMENEZ JF, ET AL: Cytokine balance in infants undergoing cardiac operation. Ann Thorac Surg 2002; 73: 601-608. discussion 608-609.
WAN S, YIM AP, ARIFI AA, LEE TW, DESMET JM, LE CLERC JL, VINCENT JL: Can cardioplegia management influence cytokine responses during clinical cardiopulmonary bypass. Ann Thorac Cardiovasc Surg 1999; 5: 81-5.
STEINBERG BM, GOSSI EA, SCHWARTZ DS, MC LOUGHLIN DE, AGUINAGA M, BIZEKIS C, GREENWALD J, FLISSER A, SPENCER FC, GALLOWAY AC, CALVIN SB: Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 1995; 60 :525-529.
MORGAN IS, CODISPOTI M, SANGER K, MANKSD PS: Superiority of centrifugal pump over roller pump in paediatric cardiac surgery: prospective randomized trial. Eur J Cardiothorac Surg 1998; 13: 526-32.
ASHRAF SS, TIAN Y, COWAN D, SHAIKH R, PARSOLE M, MARTIN, WATTERSON KG: Proinflammatory cytokine release during pediatric cardiopulmonary bypass: Influence of centrifugal and roller pumps. J Cardiothorac Vas Anesth 1997; 11: 718-22.
GILLILAND HE, ARMSTRONG A, MC MURRAY TJ: The inflammatory response to pediatric cardiac surgery: correlation of granulocyte adhesion molecule expression with postoperative oxygenation. Anesth Analg 1999; 89: 1188-91.
HÖVELS-GÜRICH HH, VAZQUEZ-JIMENEZ JF, SILVESTRI A, ET AL: Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of great arteries. J Thorac Cardiovasc Surg 2002; 124: 811-820.
VAZQUEZ-JIMENEZ JF, QUING M, HERMANNS B, ET AL: Moderate hypothermia during cardiopulmonary bypass reduces myocardial cell damage and myocardial cell death related to cardiac surgery. J Am Coll Cardiol 2001; 38: 1216-1233.
SEGHAYE MC, DUCHATEAU J, GRABITZ RG, ET AL: Histamine liberation related to cardiopulmonary bypass in children: possible relation to transient postoperative arrhythmias. J Thorac Cardiovasc Surg 1996;111:971-981.
MARTINEZ-PELLUS AF, MERINO P, BRU M, CANOVAS J, SELLER G, SAPINA J, FUENTES T, MORO J: Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass. Intens Care Med 1997; 23: 1251-7.
LEVI M, CROMHEECKE ME, DE JONGE E, PRINS MH, DE MOL BJ, BRIET E, BULLER HR: Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta- analysis of clinically relevant endopoints. Lancet 1999; 354: 1940-7.
MOJCIK CF, LEVI JH: Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 2001; 71: 745-754.
FOX AA, SHERNAN SK, BODY SC, COLLARD CD: Genetic influences on cardiac surgical outcomes. J Cardiothorac Vasc Anesth 2005; 19: 379-391.